Lucintel's latest market report analyzed that recombinant DNA technology provides attractive opportunities in biotechnology & pharmaceutical companies and academic & government research institutes. The recombinant DNA technology market is expected to grow at a CAGR of 6%-8%. In this market, medical are the largest segment by product, whereas biotechnology and pharmaceutical companies are largest by end use.
Download Brochure of this report by clicking on https://www.lucintel.com/recombinant-dna-technology-market.aspx
Based on product, the recombinant DNA technology market is segmented into medical (therapeutic agent, human protein, and vaccine) and non-medical (biotech crops, specialty chemicals, and others). The medical segment accounted for the largest share of the market in 2020 as it has facilitated disease treatment by insertion of new genes in place of damaged & diseased genes.
Browse in-depth TOC on “Recombinant DNA Technology Market”
XX – Tables
XX – Figures
150– Pages
The recombinant DNA technology market is marked by the presence of several big and small players. Some of the prominent players offering recombinant DNA technology include F. Hoffmann-La Roche, Profacgen, Amgen, Novartis, GenScript, Pfizer, Novo Nordisk, Biogen, Biocon, GlaxoSmithKline, New England Biolabs, Cibus, Monsanto Company, and Horizon Discovery Group.
Request Sample Report:
https://www.lucintel.com/recombinant-dna-technology-market.aspx
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link [email protected].
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. 972.636.5056
Cell: 303.775.0751

Related reports
Surgical Instrument Tracking System Market:
For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx

Metabolomics Market:
For more details click here https://www.lucintel.com/metabolomics-market.aspx

Industrial Microbiology Market:
For more details click here https://www.lucintel.com/industrial-microbiology-market.aspx

Surgical Microscope Market:
For more details click here https://www.lucintel.com/surgical-microscope-market.aspx

Tumor Ablation Market:
For more details click here https://www.lucintel.com/tumor-ablation-market.aspx

Vitamin D Market:
For more details click here https://www.lucintel.com/vitamin-d-market.aspx

Urology Device Market:
For more details click here https://www.lucintel.com/urology-device-market.aspx

Halal Ingredient Market:
For more details click here https://www.lucintel.com/halal-ingredient-market.aspx

Gene Expression Market:
For more details click here https://www.lucintel.com/gene-expression-market.aspx

GMO Testing Market:
For more details click here https://www.lucintel.com/gmo-testing-market.aspx